Literature DB >> 9172810

Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma.

H Kaneko1, K Sugita, N Kiyokawa, K Iizuka, K Takada, M Saito, K Yoshimoto, M Itakura, Y Kokai, J Fujimoto.   

Abstract

Expression of the intercellular adhesion molecule-1 (CD54) as well as the mutations of p53 gene were studied in childhood Burkitt's lymphoma (BL). Expression of CD54 was identified in 6 of 15 fresh BL cases. Mutations of p53 gene, analyzed by polymerase chain reaction-single stranded chain polymorphism followed by sequencing, were found in 5 of 14 cases examined. Interestingly, all the cases with p53 mutation were CD54 negative. This high frequency of p53 mutation in the CD54 negative group prompted us to analyze the clinical features of these cases. Six of 15 cases died within 21 months after initiation of therapy and five of these were CD54 negative. In addition, four of these had p53 mutation. These results suggest that the lack of CD54 by BL cells may provide the background for the mutation of p53 gene to occur which could result in the transformation to a more aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9172810     DOI: 10.3109/10428199609093443

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner.

Authors:  Vassilis G Gorgoulis; Panayotis Zacharatos; Athanassios Kotsinas; Dimitris Kletsas; George Mariatos; Vassilis Zoumpourlis; Kevin M Ryan; Christos Kittas; Athanasios G Papavassiliou
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

2.  Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma.

Authors:  Enrico Derenzini; Ilaria Iacobucci; Claudio Agostinelli; Enrica Imbrogno; Clelia Tiziana Storlazzi; Alberto L Abbate; Beatrice Casadei; Anna Ferrari; Andrea Ghelli Luserna Di Rora; Giovanni Martinelli; Stefano Pileri; Pier Luigi Zinzani
Journal:  Exp Hematol Oncol       Date:  2015-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.